Insulin receptor substrate 1 (IRS1) is the main adaptor molecule in insulin and insulin like growth factor signaling. Increased level of expression of IRS1 and IGF-1R proteins are associated with many human malignancies. They also induced resistance to therapeutic approaches such as chemo-and radiotherapy in cancer treatment however their molecular mechanisms are still unclear. Glioblastoma Multiforme (GBM) is the most common primary brain tumor in adults and radiotherapy has a pivotal role in its treatment. In this study, it is aimed to determine the relationship between IRS1 expression and radiosensitivity of GBM cells. Therefore, A172 cells transfected with pcDNA3.1 -HA-tagged human IRS1 gene. Its overexpression was confirmed by western blot. IRS1 overexpressed A172 cells were irradiated with 5,8 and 10 Gray ionizing radiation and their effects on cell viability determined by MTT and clonogenic assay. Our results showed that overexpression of IRS1 led a decrease on sensitivity of the radiation in GBM cel ls. As a conclusion, this study should be confirmed by further molecular analysis and in vivo studies. IRS1 may be a predictive marker of radiosensitivity for GBM.
Introduction
Insulin like growth factor (IGF) signaling has crucial roles in the progress of cancer (1) (2) (3) . Its overexpression is associated with proliferation, metastasis, chemo and radioresistance in many cancer types such as ovarian, breast and colorectal (4) (5) (6) . IGF binds and activates to insulin like growth factor receptor (IGF-1R). IGF-1R activation triggers the signaling pathways that mediates proliferation, cell survival and metastasis (7) . Insulin receptor substrate 1 (IRS1) is the main adaptor molecule that interacts with IGF-1R after ligand binding. IGF-1R phosphorylates tyrosine residues of IRS1 that leads to activation of IRS1 proteins. Activated IRS1 induces the activation of AKT and MAPK proteins that regulates metabolic and proliferative functions of the cells (8, 9) . Therefore, IRS1 overexpression is an important factor in tumorigenesis. Although, functions of IGFR pathway have been well-explored in cancer during recent years (7) , its effects on radiotherapy remain unclear. Radiotherapy is one of the main therapeutic approach used in cancer treatment (10, 11) . Ionizing radiation induces different cell death mechanisms through different damages in DNA. These damages could be oxidizing of DNA bases, single strand and double strand breaks and activation of different signaling pathways including IGF-1R (12, 13) . IGF-1R overexpression is known to inhibit radiation-induced cell death in mouse embryo fibroblast whereas its downregulation was shown to increase apoptosis (14) . In addition to IGF-1R overexpression, elevation of IRS1 expression also induced radioresistance in estrogen receptor-positive breast cancer cell line (15) . Overexpression IRS1 induced resistance to activation-cell death in T-Cell Hybridoma (16) . Clinical results confirmed these in vitro studies too. Many clinical studies showed that IGF-1R overexpression is correlated with disease recurrence after radiotherapy in breast cancer and cervical cancer patients (17, 18) . Glioblastoma multiforme (GBM) is one of the most frequent and aggressive type of intracranial tumors and radiotherapy is commonly used as a therapeutic approaches in treatment (19) . Osuka et al. showed that overexpression of IGF-1R led an increase radioresistance of GBM (20) .
Although there are many studies that showed the association between expression of IGF-1R and response to radiotherapy, there is not enough information about its molecular mechanisms. In this study, it is aimed to determine the effects of IRS1 overexpression on radiosentivity of GBM cell line.
Material and Methods
Reagents and Cell Culture: IRS1 and Beta Actin antibodies were obtained from Santa Cruz 
Results
Ectopic expression of IRS1 was confirmed by western blot analysis and IRS1 transfected A172 cells were found to have higher level of IRS1 expression compared to mock transfected and control group (Figure 1) . We wanted to determine the effects IRS1 overexpression on radiation. Therefore, we treated A172 cells at 5, 8 and 10 Gray radiation and incubated for 24, 48 and 72 hours. Results showed that overexpression of IRS1 led an increase radioresistance of glioblastoma cells significantly compared to control cells in all incubation groups (Figure 2 , Table 1 ) (p<0.05). Effects of radiation induced the cell death after 72h and 8 gray radiation dose was observed as an effective dose for glioblastoma cell lines. It was also shown that, radiation treatment had its apoptotic activity after 72 hours in IRS1 overexpression groups. Significant changes in cell death between IRS1 overexpression groups that were incubated for different time lenghts were not observed (Table 1 ) (p>0.05).
The differences in viability of all groups were assessed by clonogenic assay. Therefore, the cells were treated at 8 Gray as an optimum dose and incubated for 9 days. Clonogenic assay results showed that 8 Gray radiation led a decrease level on the survival of all cells compared to their untreated groups, however IRS1 overexpression group was found to more resistant to radiotherapy compare to the other groups (Figure 3) . In control and mock transfected groups, colony numbers decreased 60% after 8 Gray radiation treatment whereas we only 20% decreased was observed in colony numbers in IRS1 overexpressing group after the same treatment.
Discussion
Increased expression levels of IGF-1R and IRS1 are associated with many human malignancies which implies that both of the proteins have a pivotal role in carcinogenesis (9, 21, 22) . Recent studies have also shown that IGF-1R and IRS1 are responsible for the development of chemo-and radioresistance in cancer cells but their molecular mechanisms have not been discovered yet (23) . Radiotherapy has a crucial role in glioblastoma treatment. However, resistance to radiation is a major concern on the treatment of GBM (24) . Therefore, clarifying the molecular pathways is so important to develop new therapeutic options in GBM. This is the first report that shows the correlation between IRS1 overexpression and radioresistance in GBM cell line. Our results showed IRS1 overexpression significantly induced radioresistance in GBM cell line. Ionizing radiation produces DNA damage either by singlestrand and double-strand DNA breaks (DSB). Radiotherapy induced DNA damage activates several pathways including DNA damage response to protect the cells against genomic instability (11, 23) . During DNA repairing pathway, IRS1 can interact with RAD51 protein that is responsible for DSB repairing system (25) . In this study, it is possible that overexpression of IRS1 may lead an increase on the interaction with RAD51 and induce DNA repairing system. This molecular mechanism could be one of the main reason of resistance in A172 cells. AKT, MAPK, PI3K and mTOR are the main downstream targets of IRS1 protein (26) . All these proteins promote DNA repair systems through different signaling pathways such as XRCC1, BRCA1, FANCD2 (27) (28) (29) (30) . Increasing the level of IRS1 in A172 cells may trigger DNA damage response system via activation of AKT, mTOR and MAPK pathways and these activations may result in radioresistance. GLUT1 is widely expressed glucose transporter in human tissues (31) . GLUT1 overexpression is associated with radioresistance in different cancer types (32, 33) . Its expression is induced by many oncogenes such as MAPK and AKT during carcinogenesis and hypoxia (31) . During insulin signaling, glucose uptake rates of the cells is regulated by IRS1 proteins through the activation of AKT and translocation of GLUT proteins to the cell membrane (9) . GLUT1 expression could be elevated by increased IRS1 expression in A172 cells and this overexpression may cause to reduce the sensitivity to radiotherapy. As a summary, overexpression of IRS1 promotes resistance to radiotherapy in GBM cells via different molecular mechanisms. All these mechanisms should be confirmed by further molecular analysis and in vivo studies.
